Medicago與葛蘭素史克疫苗臨床試驗報佳音 | 國際 | 中央社 CNA
加拿大生技公司Medicago與英國大藥廠葛蘭素史克(GlaxoSmithKline)今天宣布,雙方合作研發的2019冠狀病毒疾病(COVID-19)候選疫苗的期中試驗報佳音。
加拿大生技公司Medicago與英國大藥廠葛蘭素史克(GlaxoSmithKline)今天宣布,雙方合作研發的2019冠狀病毒疾病(COVID-19)候選疫苗的期中試驗報佳音。
During the span of the COVID-19 pandemic, mRNA vaccines have gone from being promising technology in the lab to blockbuster products in the real world. In the pandemic's second year, Medicago is hopin
The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.